Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 5 | 2022 | 40 | 3.640 |
Why?
|
| Aerospace Medicine | 4 | 2022 | 22 | 2.570 |
Why?
|
| Urethral Stricture | 16 | 2022 | 19 | 2.560 |
Why?
|
| Urethra | 16 | 2022 | 56 | 1.720 |
Why?
|
| Urologic Surgical Procedures, Male | 15 | 2022 | 20 | 1.470 |
Why?
|
| Urinary Sphincter, Artificial | 5 | 2022 | 6 | 0.910 |
Why?
|
| Hypoxia | 8 | 2023 | 169 | 0.870 |
Why?
|
| Wearable Electronic Devices | 1 | 2023 | 16 | 0.860 |
Why?
|
| Aircraft | 2 | 2019 | 30 | 0.810 |
Why?
|
| Weightlessness | 1 | 2021 | 25 | 0.790 |
Why?
|
| Iron | 2 | 2016 | 197 | 0.750 |
Why?
|
| Acceleration | 4 | 2022 | 37 | 0.660 |
Why?
|
| Emergencies | 1 | 2019 | 107 | 0.660 |
Why?
|
| Moon | 1 | 2018 | 4 | 0.640 |
Why?
|
| Teaching | 2 | 2011 | 169 | 0.600 |
Why?
|
| Pulmonary Artery | 2 | 2015 | 323 | 0.540 |
Why?
|
| Air Travel | 1 | 2015 | 2 | 0.520 |
Why?
|
| Urinary Incontinence, Stress | 3 | 2022 | 60 | 0.500 |
Why?
|
| Critical Illness | 1 | 2016 | 191 | 0.500 |
Why?
|
| Humans | 46 | 2023 | 68549 | 0.500 |
Why?
|
| Writing | 2 | 2013 | 29 | 0.490 |
Why?
|
| Polycythemia | 2 | 2017 | 3 | 0.460 |
Why?
|
| Professional Competence | 2 | 2011 | 100 | 0.460 |
Why?
|
| Schools, Medical | 3 | 2013 | 157 | 0.450 |
Why?
|
| Centrifugation | 2 | 2022 | 16 | 0.420 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 281 | 0.420 |
Why?
|
| Metabolomics | 2 | 2022 | 28 | 0.400 |
Why?
|
| Bacterial Proteins | 3 | 2022 | 244 | 0.400 |
Why?
|
| Urinary Tract Infections | 2 | 2022 | 71 | 0.380 |
Why?
|
| Models, Organizational | 1 | 2011 | 97 | 0.370 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2008 | 58 | 0.370 |
Why?
|
| Postoperative Complications | 5 | 2022 | 1615 | 0.330 |
Why?
|
| Carbon Dioxide | 3 | 2023 | 78 | 0.320 |
Why?
|
| Blood Pressure | 3 | 2022 | 1449 | 0.320 |
Why?
|
| Residential Facilities | 1 | 2008 | 5 | 0.310 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 13 | 0.310 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2008 | 10 | 0.310 |
Why?
|
| Volunteers | 1 | 2008 | 30 | 0.310 |
Why?
|
| Male | 30 | 2022 | 37283 | 0.300 |
Why?
|
| Urinary Incontinence, Urge | 2 | 2018 | 12 | 0.300 |
Why?
|
| Endoscopy | 2 | 2021 | 464 | 0.280 |
Why?
|
| Peer Group | 1 | 2007 | 104 | 0.270 |
Why?
|
| Oximetry | 2 | 2023 | 29 | 0.270 |
Why?
|
| Retrospective Studies | 16 | 2022 | 7268 | 0.270 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 202 | 0.260 |
Why?
|
| Cystoscopy | 3 | 2020 | 23 | 0.250 |
Why?
|
| Educational Measurement | 1 | 2007 | 254 | 0.250 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 378 | 0.250 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2016 | 131 | 0.240 |
Why?
|
| Mutation | 2 | 2017 | 1213 | 0.240 |
Why?
|
| Urologic Surgical Procedures | 2 | 2022 | 47 | 0.230 |
Why?
|
| NAD | 2 | 2022 | 73 | 0.230 |
Why?
|
| Hyperventilation | 1 | 2023 | 6 | 0.220 |
Why?
|
| Forced Expiratory Volume | 2 | 2017 | 87 | 0.220 |
Why?
|
| Altitude | 3 | 2023 | 17 | 0.220 |
Why?
|
| Middle Aged | 16 | 2022 | 21119 | 0.220 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2022 | 1 | 0.220 |
Why?
|
| Plant Immunity | 1 | 2022 | 1 | 0.220 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2022 | 5 | 0.220 |
Why?
|
| Heart | 1 | 2008 | 850 | 0.220 |
Why?
|
| Oxygen | 2 | 2023 | 386 | 0.220 |
Why?
|
| Adult | 17 | 2020 | 21379 | 0.220 |
Why?
|
| Penile Prosthesis | 1 | 2022 | 3 | 0.210 |
Why?
|
| Penile Implantation | 1 | 2022 | 2 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2022 | 346 | 0.210 |
Why?
|
| Erectile Dysfunction | 1 | 2022 | 22 | 0.210 |
Why?
|
| Toll-Like Receptors | 1 | 2022 | 56 | 0.210 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2022 | 62 | 0.210 |
Why?
|
| Wound Infection | 1 | 2022 | 20 | 0.200 |
Why?
|
| Artifacts | 1 | 2022 | 125 | 0.200 |
Why?
|
| Tomography | 1 | 2021 | 9 | 0.200 |
Why?
|
| Anesthetists | 1 | 2021 | 5 | 0.200 |
Why?
|
| Reoperation | 2 | 2021 | 467 | 0.200 |
Why?
|
| Thiazolidines | 1 | 2021 | 23 | 0.200 |
Why?
|
| Proline | 1 | 2021 | 52 | 0.200 |
Why?
|
| Gravitation | 1 | 2021 | 12 | 0.200 |
Why?
|
| Bacteria | 1 | 2022 | 193 | 0.190 |
Why?
|
| Urination | 2 | 2018 | 19 | 0.190 |
Why?
|
| Short Chain Dehydrogenase-Reductases | 1 | 2020 | 1 | 0.190 |
Why?
|
| Burkholderia | 1 | 2020 | 2 | 0.190 |
Why?
|
| Reducing Agents | 1 | 2020 | 5 | 0.190 |
Why?
|
| Phosphines | 1 | 2020 | 5 | 0.190 |
Why?
|
| Dithiothreitol | 1 | 2020 | 17 | 0.190 |
Why?
|
| Urography | 1 | 2020 | 21 | 0.190 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2020 | 7 | 0.190 |
Why?
|
| Kidney | 2 | 2016 | 945 | 0.190 |
Why?
|
| Antimicrobial Stewardship | 1 | 2020 | 33 | 0.180 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 189 | 0.180 |
Why?
|
| Phosphorus | 1 | 2020 | 64 | 0.180 |
Why?
|
| Hemodynamics | 1 | 2022 | 705 | 0.170 |
Why?
|
| Radiotherapy | 1 | 2020 | 86 | 0.170 |
Why?
|
| Recurrence | 5 | 2021 | 948 | 0.170 |
Why?
|
| Pelvic Bones | 1 | 2019 | 7 | 0.170 |
Why?
|
| Aged | 10 | 2021 | 14842 | 0.170 |
Why?
|
| South Carolina | 4 | 2013 | 2752 | 0.170 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 168 | 0.170 |
Why?
|
| Echocardiography, Doppler | 2 | 2017 | 87 | 0.160 |
Why?
|
| Prostatic Neoplasms | 2 | 2022 | 778 | 0.160 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 3256 | 0.160 |
Why?
|
| Cohort Studies | 5 | 2020 | 2356 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 2019 | 132 | 0.160 |
Why?
|
| Dilatation | 1 | 2018 | 58 | 0.150 |
Why?
|
| Faculty, Medical | 2 | 2010 | 110 | 0.150 |
Why?
|
| Replantation | 1 | 2017 | 8 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2017 | 6 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2021 | 617 | 0.150 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2017 | 24 | 0.150 |
Why?
|
| Lung | 1 | 2021 | 849 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 114 | 0.140 |
Why?
|
| Hepcidins | 1 | 2016 | 6 | 0.140 |
Why?
|
| Phlebotomy | 1 | 2016 | 17 | 0.130 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2015 | 3 | 0.130 |
Why?
|
| Acclimatization | 1 | 2015 | 14 | 0.130 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 28 | 0.130 |
Why?
|
| Systole | 1 | 2015 | 149 | 0.130 |
Why?
|
| Female | 10 | 2016 | 38021 | 0.130 |
Why?
|
| Cystectomy | 1 | 2014 | 13 | 0.120 |
Why?
|
| Heart Rate | 1 | 2017 | 568 | 0.120 |
Why?
|
| Mitomycin | 1 | 2014 | 27 | 0.120 |
Why?
|
| Urinary Bladder Diseases | 1 | 2014 | 26 | 0.120 |
Why?
|
| Athletic Injuries | 1 | 2015 | 73 | 0.120 |
Why?
|
| Phenotype | 1 | 2017 | 946 | 0.120 |
Why?
|
| Arctic Regions | 2 | 2013 | 4 | 0.120 |
Why?
|
| Phoca | 1 | 2013 | 1 | 0.120 |
Why?
|
| Trauma Centers | 1 | 2015 | 197 | 0.110 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2013 | 25 | 0.110 |
Why?
|
| Consumer Behavior | 1 | 2013 | 68 | 0.110 |
Why?
|
| Protein Domains | 2 | 2022 | 74 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2013 | 269 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2324 | 0.090 |
Why?
|
| Total Quality Management | 1 | 2010 | 45 | 0.090 |
Why?
|
| Health Occupations | 1 | 2010 | 28 | 0.090 |
Why?
|
| Seals, Earless | 1 | 2009 | 3 | 0.090 |
Why?
|
| Water Pollutants, Chemical | 1 | 2013 | 328 | 0.080 |
Why?
|
| Quality of Life | 1 | 2017 | 1515 | 0.080 |
Why?
|
| Interprofessional Relations | 1 | 2010 | 188 | 0.080 |
Why?
|
| Medicare | 1 | 2011 | 316 | 0.080 |
Why?
|
| Curriculum | 1 | 2013 | 575 | 0.080 |
Why?
|
| Mammography | 1 | 2011 | 310 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2010 | 311 | 0.080 |
Why?
|
| Hypercapnia | 1 | 2008 | 17 | 0.080 |
Why?
|
| Young Adult | 2 | 2019 | 5710 | 0.080 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2007 | 15 | 0.080 |
Why?
|
| Respiratory Function Tests | 1 | 2008 | 123 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2018 | 85 | 0.080 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2007 | 34 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2022 | 7028 | 0.070 |
Why?
|
| Anastomosis, Surgical | 2 | 2017 | 104 | 0.070 |
Why?
|
| Risk Factors | 4 | 2020 | 5720 | 0.070 |
Why?
|
| Prostatectomy | 2 | 2020 | 87 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 791 | 0.070 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 123 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 579 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2022 | 2689 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2077 | 0.070 |
Why?
|
| Health Surveys | 1 | 2008 | 488 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2007 | 331 | 0.060 |
Why?
|
| Injury Severity Score | 2 | 2016 | 204 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 1026 | 0.060 |
Why?
|
| Prevalence | 2 | 2018 | 1609 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 2004 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2022 | 54 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2022 | 18 | 0.050 |
Why?
|
| Isomerism | 1 | 2022 | 63 | 0.050 |
Why?
|
| Tryptophan | 1 | 2022 | 65 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 45 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2022 | 15 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2022 | 14 | 0.050 |
Why?
|
| Sinorhizobium meliloti | 1 | 2021 | 1 | 0.050 |
Why?
|
| Enzyme Assays | 1 | 2021 | 5 | 0.050 |
Why?
|
| Pregnancy | 1 | 2007 | 2334 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3703 | 0.050 |
Why?
|
| Cysteine | 1 | 2021 | 112 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1533 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 236 | 0.050 |
Why?
|
| Nitrofurantoin | 1 | 2020 | 6 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2022 | 301 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2021 | 131 | 0.050 |
Why?
|
| Mycobacterium smegmatis | 1 | 2020 | 5 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 72 | 0.050 |
Why?
|
| Disulfides | 1 | 2020 | 40 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 4655 | 0.040 |
Why?
|
| Adolescent | 3 | 2019 | 8904 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 1047 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2020 | 100 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 94 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 742 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 330 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2020 | 362 | 0.040 |
Why?
|
| Device Removal | 1 | 2020 | 100 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 567 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 349 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2020 | 368 | 0.040 |
Why?
|
| United States | 3 | 2017 | 7338 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 306 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2798 | 0.040 |
Why?
|
| Spirometry | 1 | 2017 | 47 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2017 | 133 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 536 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1582 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 130 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1465 | 0.030 |
Why?
|
| Altitude Sickness | 1 | 2016 | 5 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 33 | 0.030 |
Why?
|
| Animals | 2 | 2013 | 20880 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 772 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 216 | 0.030 |
Why?
|
| Abbreviated Injury Scale | 1 | 2015 | 12 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 621 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2014 | 25 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 506 | 0.030 |
Why?
|
| Northwest Territories | 1 | 2013 | 1 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 31 | 0.030 |
Why?
|
| Insecticides | 1 | 2013 | 43 | 0.030 |
Why?
|
| Seasons | 1 | 2013 | 129 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1851 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4843 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2013 | 221 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 180 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2013 | 147 | 0.030 |
Why?
|
| Longevity | 1 | 2011 | 59 | 0.020 |
Why?
|
| Students, Medical | 1 | 2013 | 210 | 0.020 |
Why?
|
| Education, Professional | 1 | 2010 | 25 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 2093 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 214 | 0.020 |
Why?
|
| Health Status | 1 | 2011 | 429 | 0.020 |
Why?
|
| Child | 1 | 2016 | 6401 | 0.020 |
Why?
|